CA2559080A1 — A dispensing device
Assigned to Glaxo Group Ltd · Expires 2005-09-22 · 21y expired
What this patent protects
An inhaler is provided with a restricting member (6) to prevent unintentional actuation of the inhaler. Also provided is an inhaler with an extensible strap (2) joining a dust cap (5) to the housing (1) of an inhaler, the strap being particularly suited for use with inhalers that…
USPTO Abstract
An inhaler is provided with a restricting member (6) to prevent unintentional actuation of the inhaler. Also provided is an inhaler with an extensible strap (2) joining a dust cap (5) to the housing (1) of an inhaler, the strap being particularly suited for use with inhalers that comprise a restricting member. The inhaler is useful, for example, in the treatment of asthma.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.